Latest Health News
Trump’s One Big Beautiful Bill Act Darkens Outlook for Government-Backed Clinics
Bluestem Health in Nebraska, serving 21,000 low-income patients, faces worsening finances as the state implements Medicaid work requirements under President Trump’s new act, becoming the first to do so. CEO Brad Meyer fears losses for uninsured patients. This could broadly impact government-backed clinics.
Title X Funding for Reproductive Health Care at Risk Due to Trump Admin Delays
Federal Title X grants, vital for clinics providing birth control, cancer screenings, and HIV testing to 2.8 million low-income people, may lapse on April 1 without renewal. Delays by the Trump administration threaten reproductive health services nationwide. Clinics depend on these funds annually.
Medicaid Cuts Threaten Hundreds of Hospitals Across the US
Over 400 hospitals risk closure or service cuts from Medicaid reductions in Trump’s 'big, beautiful bill,' per Public Citizen analysis. This endangers care access for millions and jobs for healthcare workers, as Medicaid funds one-fifth of hospital spending. Impacts are nationwide.
WHO Hosts Global Consultation on Next Digital Health Strategy (2028-2033)
A WHO webinar today gathers stakeholders to shape the successor to the 2020-2025 Global Strategy on Digital Health, addressing fragmentation, interoperability, and AI integration. It reviews past progress and aligns with global digital processes like WSIS eHealth. Inputs will inform the draft strategy.
UC Davis Students Spotlight Health Issues for Displaced Communities
Medical students at UC Davis highlight infectious diseases, chronic conditions, and maternal-child health challenges facing refugees and asylum seekers. The event focuses on global health disparities for these vulnerable groups. It occurred on April 1, 2026.
NHS Set to Miss Key March 2026 Waiting Time Targets
UK NHS expected to miss 65% elective care within 18 weeks and 78% A&E four-hour targets, with only one-third of trusts meeting goals in January. New GP referral quotas aim to reduce lists. February A&E performance was 74.1%.
Eli Lilly Demands Higher NHS Drug Prices for UK Investment Resumption
US firm Eli Lilly conditions resumed UK investment on NHS accepting regular drug price hikes and ending a ÂŁ1.8 billion rebate scheme. Talks are optimistic for summer agreement. This affects medicine affordability.
Ray Therapeutics Gains FDA RMAT Designation for RTx-015 in Retinitis Pigmentosa
FDA grants Regenerative Medicine Advanced Therapy status to Ray Therapeutics' optogenetic therapy RTx-015 for retinal degenerative disease retinitis pigmentosa. This accelerates development for affected patients. Announcement on April 1, 2026.
Voro Therapeutics to Present Preclinical Data on PrimeBody Platform at AACR 2026
Voro Therapeutics announces oral presentations on its tumor-activated PrimeBody biologics for cancer at AACR 2026 and AET Europe, showcasing improved therapy safety and efficacy. Data highlights platform potential. Scheduled for April 1, 2026 release.
bioAffinity Technologies Reports 146% Surge in CyPath Lung Test Sales Q1 2026
CyPath Lung test unit sales rose 146% year-over-year in Q1 2026, targeting the $3.58 billion US market for lung cancer detection. This indicates growing adoption of the diagnostic tool. Reported April 1, 2026.
SAS Predicts AI and Data Advances in Health and Life Sciences for 2026
Experts forecast data orchestration for personalized medicine, quantum machine learning for drug toxicology, in-home care tech growth, and AI clinical decision support in 2026. These evolve healthcare toward precision and efficiency. Emphasis on multimodal analysis.
Global Health Financing Transition Urged to Protect Africa's Gains
Shifting donor priorities and fiscal pressures demand protecting Africa's health achievements amid changing global financing. Traditional funders face constraints, risking hard-won progress. Calls for strategic safeguards.